Low-Molecular-Weight Heparin Use in a Case of Noncardiogenic Multifocal Perinatal Thromboembolic Stroke : Table 1

]>Low-Molecular-Weight Heparin Use in a Case of Noncardiogenic Multifocal Perinatal Thromboembolic Stroke : Table 1

Table 1: Thrombophilia Evaluation Performed [10, 11].


Test	Performed	Test	Performed

PT	and	Anti-B2 glycoprotein IgG	1 and 2
INR	1 and 2	Anti-B2 glycoprotein IgM	1 and 2
aPTT	1 and 2	Anti-phosphatidylserine IgG	1 and 2
Fibrinogen	1 and 2	Anti-phosphatidylserine IgM	1 and 2
Factor V Leiden	1	Heparin cofactor 2	1 and 2
Prothrombin 20210	1	Homocysteine	1 and 2
MTHFR	1	Lipoprotein (A)	1 and 2
Protein C activity	1 and 2	Antithrombin	1 and 2
Protein S activity	1 and 2	Factor VIII activity	2
Anticardiolipin IgG	1 and 2	Lupus anticoagulant	2
Anticardiolipin IgM	1 and 2	Factor XII activity	2
Plasminogen	2

PT: prothrombin time; aPTT: activated partial thromboplastin time; INR: international normalized ratio; MTHFR: methylenetetrahydrofolate reductase.
Test performed at day of life no. 4; Test performed at four months of age.